Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine in Pediatric Relapsed/Refractory AML
NCT00042354Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2002
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by Sanofi. Started May 2002; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00042354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042354.